<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0435">
 <element-citation publication-type="journal" id="sbref0435">
  <person-group person-group-type="author">
   <name>
    <surname>El-Moamly</surname>
    <given-names>A.A.</given-names>
   </name>
   <name>
    <surname>El-Sweify</surname>
    <given-names>M.A.</given-names>
   </name>
   <name>
    <surname>Rashad</surname>
    <given-names>R.M.</given-names>
   </name>
   <name>
    <surname>Abdalla</surname>
    <given-names>E.M.</given-names>
   </name>
   <name>
    <surname>Ragheb</surname>
    <given-names>M.M.</given-names>
   </name>
   <name>
    <surname>Awad</surname>
    <given-names>M.M.</given-names>
   </name>
  </person-group>
  <article-title>Role of CCR5Î”32 mutation in protecting patients with 
   <italic>Schistosoma mansoni</italic> infection against hepatitis C viral infection or progression
  </article-title>
  <source>Parasitol. Res.</source>
  <volume>112</volume>
  <year>2013</year>
  <fpage>2745</fpage>
  <lpage>2752</lpage>
  <pub-id pub-id-type="doi">10.1007/s00436-013-3380-9</pub-id>
  <pub-id pub-id-type="pmid">23515570</pub-id>
 </element-citation>
</ref>
